Basic Information
| LncRNA/CircRNA Name | RNA95271 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | Microarray, qPCR etc. |
| Sample | PTC tissues |
| Expression Pattern | down-regulated |
| Function Description | We selected the top 3 up- and down-regulated lncRNAs and another random 4 differentially expressed lncRNAs and measured their expression in 55 pairs of PTC and corresponding noncancerous thyroid tissues using qRT-PCR. These qRT-PCR results are consistent with the microarray data. |
| Pubmed ID | 27929737 |
| Year | 2017 |
| Title | Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene. |
External Links
| Links for RNA95271 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |